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SUPPLEMENTARY DATA
Statistical methods for ﬁtting
weighted Coxmodels to estimate
causal hazard ratios
Pooled logistic regression models were used to approximate weighted
Cox models (due to software limitations) to estimate causal hazard
ratios for 52 weeks HC use by type versus no HC use in non-pregnant
women. Women were ‘artiﬁcially censored’ at the ﬁrst of deviation
from baseline HC or ﬁrst positive pregnancy test. Natural censoring
alsooccurredwherewomenwere lost to follow-up.The joint probability
of remaining uncensored for change inHCuse, for pregnancy and for loss
to follow-up was estimated conditional on prognostic factors to obtain
inverse-probability-of-censoring weights (weighting models). Then the
association between baseline HC type and HIV diagnosis was estimated
in a logistic regression model (outcomemodel) including baseline covari-
ates weighted using the inverse-probability-of-censoring weights.
Data were organized into 4-weekly visits. Baseline factors were those
at enrolment. Each 4-week interval, k, was bounded by (t, t + 28] with
new intervals beginning at t ¼ 0,28,56,. . . days after baseline corre-
sponding to scheduled clinic visits.
Baseline covariates in weighting and outcome models were age,
centre, education, employment status, randomized group, sexual fre-
quency, condom use, genital ﬁndings, BV result, HSV-2 result and
other STI results. Time since enrolmentwas adjusted for using restricted
cubic splines with knots at 10th, 50th and 90th percentiles (8, 28 and 48
weeks).
Let D(t) denotes an indicator of a positive HIV test during interval t.
The outcome model was deﬁned as follows:
logit(P(D(t = 1)|D(t − 1) = 0,N(t = 0),CP(t = 0),C(t = 0), V)
= u0(t) + u′1 V + u′2 X
whereN(t) denotes an indicator of artiﬁcial censoring for deviating from
baseline contraception in interval t (starting, stopping or changing type of
HC), CP(t) denotes pregnancy in interval t and C(t) denotes loss to
follow-up in interval t. V is a vector of baseline factors as described
above and X is a categorical variable for baseline contraception (no
HC, DMPA, Net-En, OC).
A subject in the risk set for interval t ((t228, t]) was weighted by the
inverse probability weight SWN(t) × SWCP(t) × SWC(t). The stabilized
inverse probability weight SWN(t) for interval t was deﬁned as
SWN(t)
=
∏t
k=1 P[(N(k) = 0|N(k− 1) = 0, CP(k) = 0, C(k) = 0, V)∏t
k=1 P(N(k) = 0|N(k− 1) = 0, CP(k) = 0, C(k) = 0, L(k− 1))
whereL(t) is history of time-dependent confounders at/prior to the end
of interval t, including baseline factors, V. Time-dependent variables
included in L(t)were sexual frequency, condom use, genital ﬁndings, BV
result and HSV-2 result and other STI results. The stabilized inverse
probability weight SWCP(t) for interval t was deﬁned as
SWCP(t)
=
∏t
k=1 P[(CP(k) = 0|CP(k− 1) = 0, N(k− 1) = 0, C(k) = 0, V)∏t
k=1 P(CP(k) = 0|CP(k− 1) = 0, N(k− 1) = 0, C(k) = 0, L(k− 1))
The stabilized inverse probability weight SWC(t) for interval t was
deﬁned as
SWC(t)
=
∏t
k=1 P[(C(k)= 0|C(k−1)= 0,N(k−1)= 0, CP(k−1)= 0, V)
∏t
k=1 P(C(k)= 0|C(k−1)= 0,N(k−1)= 0, CP(k−1)= 0,L(k−1))
The probability of censoring for change in contraceptive use was esti-
mated within strata deﬁned by centre and baseline contraceptive type.
For users of HC we ﬁtted a multinomial logistic regression model with
outcomes, no change (uncensored), stopped HC (censored) and
changed HC type remaining on HC (censored). For non-users of HC
we ﬁtted a multinomial logistic regression model with outcomes, no
change (uncensored), initiatedDMPA (censored), initiatedNet-En (cen-
sored) and initiated oral contraception (censored).
The probability of censoring for pregnancy and similarly, the probabil-
ity of censoring for loss to follow-upwere estimatedwithin strata deﬁned
by centre from a logistic regression model including baseline contracep-
tion in addition to other baseline and time-dependent covariates.
We censored at pregnancy since pregnancy cannot be included as a
standard time-dependent covariate in weighting models for deviation
from baseline contraception; the probability ofHCuse during pregnancy
is ‘zero’ (at least for initiation) leading to structural violation of positivity
assumption when using inverse probability weighting for exposure.
Results are therefore interpretable as risks associated with HC use in
non-pregnant women.
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